Capture Green Lifestyles and Win Exciting Prizes: Huawei FusionSolar Creators' Cup kicks off
SHENZHEN, China, March 26, 2025 /PRNewswire/ -- When cameras illuminate solar PV, inspiring interactions between technology and nature emerge. On March 20, 2025, Huawei FusionSolar Creators' Cup was launched, calling for creative works from global...
electronica China 2025 on the Horizon: Click to Uncover Concurrent Forums!
SHANGHAI, March 26, 2025 /PRNewswire/ -- From April 15 to 17, 2025, Shanghai New International Expo Centre will stage an annual grand event in the electronic industry—electronica China 2025. This year's exhibition has specially crafted a forum...
Alphamab Oncology Reports Full Year 2024 Financial Results and Business Highlights
SUZHOU, China, March 26, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) reported financial results for the full year ended December 31, 2024 and highlighted recent business progress. Financial Summary For the year ended December 31,...
Science! SDU Researchers Identified the Membrane Receptor for Ceramide in Adipocytes
JINAN, China, March 26, 2025 /PRNewswire/ -- Recently, Professor Sun Jinpeng's team at Shandong University and collaborators published a research paper titled "Metabolic signaling of ceramides through the FPR2 receptor inhibits adipocyte...
Basketball community unites at FIBA 3x3 Asia Cup 2025 with activities for everyone, event boasts continued sustainability efforts
SINGAPORE, March 26, 2025 /PRNewswire/ -- A week-long celebration of basketball will see the sports community come together at the Singapore Sports Hub for the FIBA 3x3 Asia Cup 2025 with exciting action on and off the court. FIBA 3x3 Asia Cup 2025...
Everest Medicines Announces Financial Results for Full Year Ended December 31, 2024
SHANGHAI, March 26, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative medicines and...
Kelun-Biotech's Radionuclide-Drug Conjugate (RDC) SKB107 Receives NMPA Approval For The Treatment of Bone Metastases in Solid Tumors
CHENGDU, China, March 26, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company has received a clinical trial notice approving the investigational new drug application for a...
Fosun Pharma Announces 2024 Annual Results
Accelerates Globalization of Innovative Products with Operating Cash Flow Surging 31.13% YoY SHANGHAI, March 26, 2025 /PRNewswire/ -- On March 25, 2025, Shanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma"or "the Group"; Stock Code:...